Robert Kopple

Kopple Klinger & Elbaz LLP provides legal services. Its practice areas include family wealth planning, business transactions, taxation , non-profit organization and trust & estate administration. The company was founded by Robert C. Kopple and Leslie S. Klinger in 1992 and is headquartered in Los Angeles, CA.

E.L. II Properties Trust engages in the estate planning activities. The company is headquartered in Los Angeles, CA.

Triton Emission Solutions, Inc. engages in the development and marketing of emission abatement technologies for the marine industry. Its products include Njord Exhaust Gas Scrubber System, which cleans the exhaust gases from excess sulfur following the internal combustion process within a ships' engine and DSOX Fuel Purification System, a pre-combustion desulfurization technology designed to remove alkali metals, such as sulfur and sodium, from heavy marine fuel and Bio Scrubber Technology, is a patented system designed to significantly reduce the maintenance cost and premature failure of gas turbine engines by removing alkali metals that are usually present in fuel. The company was founded on March 2, 2000 and is headquartered in Vancouver, Canada.

Cardero Resource Corp. is an exploration resource company, which focusses on building a base metals exploration and development. Its projects include Zonia Copper Oxide Project, Silver Queen Property and Copper Fundamentals. The company was founded by Hendrik van Alphen in December 31, 1985 and is headquartered in Vancouver, Canada.

Kopple Financial, Inc. provides investment services. The private company is based in Los Angeles.

Tradier, Inc. engages in the provision of brokerage and cloud-based financial services. It offers trading, real-time market data, and account opening and funding for investors, advisors, and funders. The company was founded by Dan Raju, Jeyashree Chidambaram, Peter Laptewicz, Steve Agalloco, and Jason Barry in 2012 and is headquartered in Charlotte, NC.

MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.